Ferreira, J. P., Claggett, B. L., Liu, J., Desai, A. S., Pfeffer, M. A., Anand, I. S., … McMurray, J. J. V. (2021). Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial. European Journal of Heart Failure, 23(5), 776–784. https://doi.org/10.1002/ejhf.2134

Ferreira, João Pedro, Brian L. Claggett, Jiankang Liu, Akshay S. Desai, Marc A. Pfeffer, Inder S. Anand, Dirk J. van Veldhuisen, et al. “Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial.” European Journal of Heart Failure 23, no. 5 (May 2021): 776–84. https://doi.org/10.1002/ejhf.2134.

Ferreira JP, Claggett BL, Liu J, Desai AS, Pfeffer MA, Anand IS, et al. Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial. European Journal of Heart Failure. 2021 May;23(5):776–84.

Ferreira, João Pedro, et al. “Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial.” European Journal of Heart Failure, vol. 23, no. 5, Oxford University Press (OUP), May 2021, pp. 776–84. Crossref, doi:10.1002/ejhf.2134.

Ferreira JP, Claggett BL, Liu J, Desai AS, Pfeffer MA, Anand IS, van Veldhuisen DJ, Kober L, Cleland JGF, Rouleau JL, Packer M, Zile MR, Shi VC, Lefkowitz MP, Shah SJ, Vardeny O, Zannad F, Solomon SD, McMurray JJV. Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial. European Journal of Heart Failure. Oxford University Press (OUP); 2021 May;23(5):776–784.